Reviewed,
UniProtKB/Swiss-Prot O15503 (INSI1_HUMAN)
Last modified
November 3, 2009.
Version 82.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Insulin-induced gene 1 protein Short name=INSIG-1 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 277 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Mediates feedback control of cholesterol synthesis by controlling SCAP and HMGCR. Functions by blocking the processing of sterol regulatory element-binding proteins (SREBPs). Capable of retaining the SCAP-SREBF2 complex in the ER thus preventing it from escorting SREBPs to the Golgi. Seems to regulate the ubiquitin-mediated proteasomal degradation of HMGCR. May play a role in growth and differentiation of tissues involved in metabolic control. May play a regulatory role during G0/G1 transition of cell growth. Ref.2 Ref.8 Ref.10 Ref.11 |
| Subunit structure | Binds to the SCAP-SREBF2 complex only in the presence of sterols. Ref.2 Ref.10 |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein. Ref.2 |
| Tissue specificity | Expressed in all tissues tested with highest expression in the liver. Ref.2 |
| Induction | By insulin. |
| Post-translational modification | Ubiquitinated. Subsequent to sterol deprivation, the SCAP-SREBF2 complex becomes dissociated from INSIG1, is then ubiquitinated and degraded in proteasomes. Although ubiquitination is required for rapid INSIG1 degradation, it is not required for release of the SCAP-SREBP complex. Ref.10 |
| Miscellaneous | Expressed at high levels when nuclear SREBP levels are high as a result of sterol deprivation. |
| Sequence similarities | Belongs to the INSIG family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cholesterol metabolism Lipid metabolism Steroid metabolism |
| Cellular component | Endoplasmic reticulum Membrane |
| Coding sequence diversity | Polymorphism |
| Domain | Transmembrane |
| PTM | Isopeptide bond Ubl conjugation |
| Technical term | Complete proteome Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | ER-nuclear sterol response pathway Inferred from direct assay. Source: UniProtKB cell proliferation Ref.1Traceable author statement. Source: ProtInc cholesterol metabolic processInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | endoplasmic reticulum Ref.2 Inferred from direct assay. Source: UniProtKB integral to membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | protein binding Ref.2 Inferred from physical interaction. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 277 | 277 | Insulin-induced gene 1 protein | PRO_0000191675 | |||||
Regions | |||||||||
| Topological domain | 1 – 87 | 87 | Cytoplasmic Ref.9 | ||||||
| Transmembrane | 88 – 108 | 21 | Potential | ||||||
| Topological domain | 109 – 126 | 18 | Lumenal Potential | ||||||
| Transmembrane | 127 – 147 | 21 | Potential | ||||||
| Topological domain | 148 – 160 | 13 | Cytoplasmic Ref.9 | ||||||
| Transmembrane | 161 – 177 | 17 | Potential | ||||||
| Topological domain | 178 – 182 | 5 | Lumenal Potential | ||||||
| Transmembrane | 183 – 203 | 21 | Potential | ||||||
| Topological domain | 204 – 209 | 6 | Cytoplasmic Ref.9 | ||||||
| Transmembrane | 210 – 230 | 21 | Potential | ||||||
| Topological domain | 231 – 241 | 11 | Lumenal Potential | ||||||
| Transmembrane | 242 – 262 | 21 | Potential | ||||||
| Topological domain | 263 – 277 | 15 | Cytoplasmic Ref.9 | ||||||
Amino acid modifications | |||||||||
| Cross-link | 156 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.10 | |||||||
| Cross-link | 158 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.10 | |||||||
Natural variations | |||||||||
| Natural variant | 27 | 1 | A → T: dbSNP rs1129825. Ref.1 | VAR_027683 | |||||
Experimental info | |||||||||
| Mutagenesis | 156 | 1 | K → R: Loss of ubiquitination and degradation. Ref.10 | ||||||
| Mutagenesis | 158 | 1 | K → R: Loss of ubiquitination and degradation. Ref.10 | ||||||
| Mutagenesis | 205 | 1 | D → A: Loss of ability to suppress the cleavage of SREBP2 and to accelerate the degradation of HMGCR. Ref.11 | ||||||
| Sequence conflict | 31 – 32 | 2 | AA → PP in AAB69121. Ref.1 | ||||||
| Sequence conflict | 99 | 1 | A → T in AAB69121. Ref.1 | ||||||
| Sequence conflict | 170 – 172 | 3 | VFV → GFG in AAB69121. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning, human chromosomal assignment, and adipose and hepatic expression of the CL-6/INSIG1 gene." Peng Y., Schwarz E.J., Lazar M.A., Genin A., Spinner N.B., Taub R. Genomics 43:278-284(1997) [PubMed: 9268630] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT THR-27. |
| [2] | "Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER." Yang T., Espenshade P.J., Wright M.E., Yabe D., Gong Y., Aebersold R., Goldstein J.L., Brown M.S. Cell 110:489-500(2002) [PubMed: 12202038] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 40-61 AND 64-83, MASS SPECTROMETRY, FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH SCAP AND SREBP2 COMPLEX. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Placenta. |
| [5] | "Human chromosome 7: DNA sequence and biology." Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., Kanematsu E., Gentles S. Tsui L.-C.Science 300:767-772(2003) [PubMed: 12690205] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Skin. |
| [8] | "Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain." Sever N., Yang T., Brown M.S., Goldstein J.L., DeBose-Boyd R.A. Mol. Cell 11:25-33(2003) [PubMed: 12535518] [Abstract] Cited for: FUNCTION. |
| [9] | "Membrane topology of human insig-1, a protein regulator of lipid synthesis." Feramisco J.D., Goldstein J.L., Brown M.S. J. Biol. Chem. 279:8487-8496(2004) [PubMed: 14660594] [Abstract] Cited for: TOPOLOGY. |
| [10] | "Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake." Gong Y., Lee J.N., Lee P.C., Goldstein J.L., Brown M.S., Ye J. Cell Metab. 3:15-24(2006) [PubMed: 16399501] [Abstract] Cited for: FUNCTION, INTERACTION WITH SCAP AND SREBP2 COMPLEX, UBIQUITINATION AT LYS-156 AND LYS-158, MUTAGENESIS OF LYS-156 AND LYS-158. |
| [11] | "Juxtamembranous aspartic acid in Insig-1 and Insig-2 is required for cholesterol homeostasis." Gong Y., Lee J.N., Brown M.S., Goldstein J.L., Ye J. Proc. Natl. Acad. Sci. U.S.A. 103:6154-6159(2006) [PubMed: 16606821] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF ASP-205. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| U96876 Genomic DNA. Translation: AAB69121.1. AY112745 mRNA. Translation: AAM44086.1. BT007227 mRNA. Translation: AAP35891.1. AK291675 mRNA. Translation: BAF84364.1. CH236962 Genomic DNA. Translation: EAL23729.1. CH471149 Genomic DNA. Translation: EAX04529.1. BC001880 mRNA. Translation: AAH01880.1. | |
| IPI | IPI00290111. |
| RefSeq | NP_005533.2. NP_938150.2. NP_938151.1. |
| UniGene | Hs.520819 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | O15503. |
PTM databases | |
| PhosphoSite | O15503. |
Proteomic databases | |
| PRIDE | O15503. |
Genome annotation databases | |
| Ensembl | ENST00000340368; ENSP00000344741; ENSG00000186480; Homo sapiens. [Genome view] ENST00000342407; ENSP00000344035; ENSG00000186480; Homo sapiens. [Genome view] ENST00000344756; ENSP00000340010; ENSG00000186480; Homo sapiens. [Genome view] ENST00000425172; ENSP00000414691; ENSG00000186480; Homo sapiens. [Genome view] |
| GeneID | 3638. |
| KEGG | hsa:3638. |
| NMPDR | fig|9606.3.peg.29764. |
| UCSC | uc003wly.1. human. |
Organism-specific databases | |
| CTD | 3638. |
| GeneCards | GC07P154720. |
| HGNC | HGNC:6083. INSIG1. |
| MIM | 602055. gene. |
| PharmGKB | PA29890. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | O15503. |
Gene expression databases | |
| ArrayExpress | O15503. |
| Bgee | O15503. |
| CleanEx | HS_INSIG1. |
| Genevestigator | O15503. |
| GermOnline | ENSG00000186480. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR009904. INSIG. [Graphical view] |
| PANTHER | PTHR15301. INSIG. 1 hit. |
| Pfam | PF07281. INSIG. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 14239. |
| SOURCE | Search... |
Entry information
| Entry name | INSI1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O15503 Secondary accession number(s): A8K6L0, Q53XW8, Q9BUV5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


